Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open and closed-loop control systems01:17

Open and closed-loop control systems

1.7K
Control systems are foundational elements in automation and engineering. They are broadly categorized into open-loop and closed-loop systems. These classifications hinge on the presence or absence of feedback mechanisms, significantly influencing the system's performance, complexity, and application.
An open-loop control system operates without feedback from the output. It consists of two primary elements: the controller and the controlled process. The controller receives an input signal...
1.7K
The Integrated Rate Law: The Dependence of Concentration on Time02:39

The Integrated Rate Law: The Dependence of Concentration on Time

43.1K
While the differential rate law relates the rate and concentrations of reactants, a second form of rate law called the integrated rate law relates concentrations of reactants and time. Integrated rate laws can be used to determine the amount of reactant or product present after a period of time or to estimate the time required for a reaction to proceed to a certain extent. For example, an integrated rate law helps determine the length of time a radioactive material must be stored for its...
43.1K
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

745
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
745
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

1.1K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.1K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

603
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
603
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.3K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-reported outcomes as early indicators of recurrence, disease progression, and survival via machine learning in breast cancer.

NPJ breast cancer·2026
Same author

Community pharmacists are not yet ready to manage oral anti-cancer agents: beyond safe dispensing and basic education.

The International journal of pharmacy practice·2026
Same author

Identification of health indicators for a health equity scorecard in ambulatory care pharmacy practice.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

Content validation of a pre-treatment oral oncolytic non-adherence estimator (ORACLE).

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Same author

Characterizing pharmacist impact in maintenance therapy for adolescent and young adults with acute lymphoblastic leukemia treated with CALGB 10403 protocol.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Same author

Database completeness and evaluation of potential barriers and facilitators of data collection in the national pediatric cancer registry in Ethiopia.

Journal of cancer policy·2026

Related Experiment Video

Updated: Feb 10, 2026

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
11:54

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

Published on: May 8, 2021

5.2K

Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy

Benyam Muluneh1, Molly Schneider1, Aimee Faso1

  • 1University of North Carolina (UNC) at Chapel Hill; UNC Medical Center, Chapel Hill, NC; and Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC.

Journal of Oncology Practice
|May 26, 2018
PubMed
Summary

A pharmacist-led oral chemotherapy management program improved patient understanding and adherence rates. This program also achieved superior major molecular response rates in chronic myeloid leukemia patients compared to existing literature.

More Related Videos

Closed-loop Neuro-robotic Experiments to Test Computational Properties of Neuronal Networks
11:18

Closed-loop Neuro-robotic Experiments to Test Computational Properties of Neuronal Networks

Published on: March 2, 2015

10.9K
Using Neuron Spiking Activity to Trigger Closed-Loop Stimuli in Neurophysiological Experiments
05:19

Using Neuron Spiking Activity to Trigger Closed-Loop Stimuli in Neurophysiological Experiments

Published on: November 12, 2019

7.5K

Related Experiment Videos

Last Updated: Feb 10, 2026

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
11:54

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

Published on: May 8, 2021

5.2K
Closed-loop Neuro-robotic Experiments to Test Computational Properties of Neuronal Networks
11:18

Closed-loop Neuro-robotic Experiments to Test Computational Properties of Neuronal Networks

Published on: March 2, 2015

10.9K
Using Neuron Spiking Activity to Trigger Closed-Loop Stimuli in Neurophysiological Experiments
05:19

Using Neuron Spiking Activity to Trigger Closed-Loop Stimuli in Neurophysiological Experiments

Published on: November 12, 2019

7.5K

Area of Science:

  • Oncology
  • Pharmacology
  • Health Services Research

Background:

  • Oral anticancer therapies are increasingly used in academic medical centers.
  • Effective management programs are crucial for optimizing patient outcomes and adherence.
  • Existing models may not fully address the complexities of oral chemotherapy administration and monitoring.

Purpose of the Study:

  • To establish an integrated, closed-loop, pharmacist-led oral chemotherapy management program.
  • To evaluate the program's impact on patient knowledge, adherence, and clinical outcomes.
  • To assess patient and provider satisfaction with the new management model.

Main Methods:

  • Implementation of a pharmacist-led oral chemotherapy management program.
  • Collection of data on adherence, patient understanding, interventions, satisfaction, and molecular response rates.
  • Pre- and postassessment tests for comprehension, medication possession ratio for adherence validation.

Main Results:

  • Patient comprehension of oral chemotherapy increased from 43% to 95%.
  • Adherence rates were high (85-94.7%) and validated by medication possession ratio.
  • The program facilitated 350 clinical pharmacist encounters and 235 interventions for 318 reported adverse effects.
  • Major molecular response rate in chronic myeloid leukemia patients was 83%, significantly higher than published trial rates (40-60%).

Conclusions:

  • The developed model significantly improved patient knowledge and adherence to oral chemotherapy.
  • Superior major molecular response outcomes were observed in chronic myeloid leukemia patients.
  • This pharmacist-led program represents a gold standard for managing patients on oral chemotherapy.